» Articles » PMID: 9421504

Activation of Stress-activated MAP Protein Kinases Up-regulates Expression of Transgenes Driven by the Cytomegalovirus Immediate/early Promoter

Overview
Specialty Biochemistry
Date 1998 Feb 28
PMID 9421504
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The immediate/early promoter/enhancer of cytomegalovirus (CMV promoter) is one of the most commonly used promoters for expression of transgenes in eukaryotic cells. In practice, the CMV promoter is often thought of as a constitutively active unregulated promoter. However, we have observed that transcription from the CMV promoter can be up-regulated by a variety of environmental stresses. Many forms of cellular stress stimulate MAP kinase signalling pathways, resulting in activation of stress-activated protein kinases [SAPKs, also called Jun N-terminal kinases (JNKs)] and p38 kinases. We have found that the same conditions that lead to activation of SAPK/JNKs and p38 kinases can also dramatically increase expression from the CMV promoter. Inhibitors of p38 kinases abolished basal transcription from the CMV promoter and completely blocked stress-induced up-regulation of the CMV promoter. Overexpression of a dominant negative JNK kinase had no effect on basal transcription, but significantly reduced up-regulation caused by stress. These results have grave implications for use of the CMV promoter. If the CMV promoter can be up-regulated by cellular stresses, inadvertent activation of the stress kinase pathways may complicate, if not invalidate, the interpretation of a wide range of experiments.

Citing Articles

A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritis.

Thampi P, Seabaugh K, Pezzanite L, Chu C, Phillips J, Grieger J Gene Ther. 2023; 30(12):792-800.

PMID: 37696981 PMC: 10727982. DOI: 10.1038/s41434-023-00420-2.


The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice.

Skandorff I, Gille J, Ragonnaud E, Andersson A, Schrodel S, Thirion C Viruses. 2023; 15(8).

PMID: 37632028 PMC: 10458386. DOI: 10.3390/v15081686.


Cell factory engineering: Challenges and opportunities for synthetic biology applications.

Bachhav B, de Rossi J, Llanos C, Segatori L Biotechnol Bioeng. 2023; 120(9):2441-2459.

PMID: 36859509 PMC: 10440303. DOI: 10.1002/bit.28365.


Gene therapy approaches for equine osteoarthritis.

Thampi P, Samulski R, Grieger J, Phillips J, McIlwraith C, Goodrich L Front Vet Sci. 2022; 9:962898.

PMID: 36246316 PMC: 9558289. DOI: 10.3389/fvets.2022.962898.


Cytoglobin inhibits non-thermal plasma-induced apoptosis in melanoma cells through regulation of the NRF2-mediated antioxidant response.

De Backer J, Lin A, Vanden Berghe W, Bogaerts A, Hoogewijs D Redox Biol. 2022; 55:102399.

PMID: 35850009 PMC: 9294208. DOI: 10.1016/j.redox.2022.102399.


References
1.
Kyriakis J, Avruch J . Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996; 271(40):24313-6. DOI: 10.1074/jbc.271.40.24313. View

2.
Giasson B, Mushynski W . Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J Biol Chem. 1996; 271(48):30404-9. DOI: 10.1074/jbc.271.48.30404. View

3.
Wesselborg S, Bauer M, Vogt M, Schmitz M, Schulze-Osthoff K . Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J Biol Chem. 1997; 272(19):12422-9. DOI: 10.1074/jbc.272.19.12422. View

4.
Sambucetti L, Cherrington J, Wilkinson G, Mocarski E . NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989; 8(13):4251-8. PMC: 401626. DOI: 10.1002/j.1460-2075.1989.tb08610.x. View

5.
Stamminger T, Fickenscher H, Fleckenstein B . Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol. 1990; 71 ( Pt 1):105-13. DOI: 10.1099/0022-1317-71-1-105. View